569 related articles for article (PubMed ID: 33828297)
1. Genome-wide enhancer maps link risk variants to disease genes.
Nasser J; Bergman DT; Fulco CP; Guckelberger P; Doughty BR; Patwardhan TA; Jones TR; Nguyen TH; Ulirsch JC; Lekschas F; Mualim K; Natri HM; Weeks EM; Munson G; Kane M; Kang HY; Cui A; Ray JP; Eisenhaure TM; Collins RL; Dey K; Pfister H; Price AL; Epstein CB; Kundaje A; Xavier RJ; Daly MJ; Huang H; Finucane HK; Hacohen N; Lander ES; Engreitz JM
Nature; 2021 May; 593(7858):238-243. PubMed ID: 33828297
[TBL] [Abstract][Full Text] [Related]
2. INFERNO: inferring the molecular mechanisms of noncoding genetic variants.
Amlie-Wolf A; Tang M; Mlynarski EE; Kuksa PP; Valladares O; Katanic Z; Tsuang D; Brown CD; Schellenberg GD; Wang LS
Nucleic Acids Res; 2018 Sep; 46(17):8740-8753. PubMed ID: 30113658
[TBL] [Abstract][Full Text] [Related]
3. An integrative functional genomics framework for effective identification of novel regulatory variants in genome-phenome studies.
Zhao J; Cheng F; Jia P; Cox N; Denny JC; Zhao Z
Genome Med; 2018 Jan; 10(1):7. PubMed ID: 29378629
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide enhancer-gene regulatory maps link causal variants to target genes underlying human cancer risk.
Ying P; Chen C; Lu Z; Chen S; Zhang M; Cai Y; Zhang F; Huang J; Fan L; Ning C; Li Y; Wang W; Geng H; Liu Y; Tian W; Yang Z; Liu J; Huang C; Yang X; Xu B; Li H; Zhu X; Li N; Li B; Wei Y; Zhu Y; Tian J; Miao X
Nat Commun; 2023 Sep; 14(1):5958. PubMed ID: 37749132
[TBL] [Abstract][Full Text] [Related]
5. Combinatorial effects of multiple enhancer variants in linkage disequilibrium dictate levels of gene expression to confer susceptibility to common traits.
Corradin O; Saiakhova A; Akhtar-Zaidi B; Myeroff L; Willis J; Cowper-Sal lari R; Lupien M; Markowitz S; Scacheri PC
Genome Res; 2014 Jan; 24(1):1-13. PubMed ID: 24196873
[TBL] [Abstract][Full Text] [Related]
6. Systematic analysis of chromatin interactions at disease associated loci links novel candidate genes to inflammatory bowel disease.
Meddens CA; Harakalova M; van den Dungen NA; Foroughi Asl H; Hijma HJ; Cuppen EP; Björkegren JL; Asselbergs FW; Nieuwenhuis EE; Mokry M
Genome Biol; 2016 Nov; 17(1):247. PubMed ID: 27903283
[TBL] [Abstract][Full Text] [Related]
7. Many inflammatory bowel disease risk loci include regions that regulate gene expression in immune cells and the intestinal epithelium.
Mokry M; Middendorp S; Wiegerinck CL; Witte M; Teunissen H; Meddens CA; Cuppen E; Clevers H; Nieuwenhuis EE
Gastroenterology; 2014 Apr; 146(4):1040-7. PubMed ID: 24333384
[TBL] [Abstract][Full Text] [Related]
8. Integrative analysis of liver-specific non-coding regulatory SNPs associated with the risk of coronary artery disease.
Selvarajan I; Toropainen A; Garske KM; López Rodríguez M; Ko A; Miao Z; Kaminska D; Õunap K; Örd T; Ravindran A; Liu OH; Moreau PR; Jawahar Deen A; Männistö V; Pan C; Levonen AL; Lusis AJ; Heikkinen S; Romanoski CE; Pihlajamäki J; Pajukanta P; Kaikkonen MU
Am J Hum Genet; 2021 Mar; 108(3):411-430. PubMed ID: 33626337
[TBL] [Abstract][Full Text] [Related]
9. Enhancer Dysfunction in 3D Genome and Disease.
Xia JH; Wei GH
Cells; 2019 Oct; 8(10):. PubMed ID: 31635067
[TBL] [Abstract][Full Text] [Related]
10. Activity-by-contact model of enhancer-promoter regulation from thousands of CRISPR perturbations.
Fulco CP; Nasser J; Jones TR; Munson G; Bergman DT; Subramanian V; Grossman SR; Anyoha R; Doughty BR; Patwardhan TA; Nguyen TH; Kane M; Perez EM; Durand NC; Lareau CA; Stamenova EK; Aiden EL; Lander ES; Engreitz JM
Nat Genet; 2019 Dec; 51(12):1664-1669. PubMed ID: 31784727
[TBL] [Abstract][Full Text] [Related]
11. Bridging between Mouse and Human Enhancer-Promoter Long-Range Interactions in Neural Stem Cells, to Understand Enhancer Function in Neurodevelopmental Disease.
D'Aurizio R; Catona O; Pitasi M; Li YE; Ren B; Nicolis SK
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887306
[TBL] [Abstract][Full Text] [Related]
12. Putative enhancer sites in the bovine genome are enriched with variants affecting complex traits.
Wang M; Hancock TP; MacLeod IM; Pryce JE; Cocks BG; Hayes BJ
Genet Sel Evol; 2017 Jul; 49(1):56. PubMed ID: 28683716
[TBL] [Abstract][Full Text] [Related]
13. Parkinson-associated risk variant in distal enhancer of α-synuclein modulates target gene expression.
Soldner F; Stelzer Y; Shivalila CS; Abraham BJ; Latourelle JC; Barrasa MI; Goldmann J; Myers RH; Young RA; Jaenisch R
Nature; 2016 May; 533(7601):95-9. PubMed ID: 27096366
[TBL] [Abstract][Full Text] [Related]
14. An encyclopedia of enhancer-gene regulatory interactions in the human genome.
Gschwind AR; Mualim KS; Karbalayghareh A; Sheth MU; Dey KK; Jagoda E; Nurtdinov RN; Xi W; Tan AS; Jones H; Ma XR; Yao D; Nasser J; Avsec Ž; James BT; Shamim MS; Durand NC; Rao SSP; Mahajan R; Doughty BR; Andreeva K; Ulirsch JC; Fan K; Perez EM; Nguyen TC; Kelley DR; Finucane HK; Moore JE; Weng Z; Kellis M; Bassik MC; Price AL; Beer MA; Guigó R; Stamatoyannopoulos JA; Lieberman Aiden E; Greenleaf WJ; Leslie CS; Steinmetz LM; Kundaje A; Engreitz JM
bioRxiv; 2023 Nov; ():. PubMed ID: 38014075
[TBL] [Abstract][Full Text] [Related]
15. Chromatin stretch enhancer states drive cell-specific gene regulation and harbor human disease risk variants.
Parker SC; Stitzel ML; Taylor DL; Orozco JM; Erdos MR; Akiyama JA; van Bueren KL; Chines PS; Narisu N; ; Black BL; Visel A; Pennacchio LA; Collins FS; ;
Proc Natl Acad Sci U S A; 2013 Oct; 110(44):17921-6. PubMed ID: 24127591
[TBL] [Abstract][Full Text] [Related]
16. The interaction between enhancer variants and environmental factors as an overlooked aetiological paradigm in human complex disease.
Robert S; Rada-Iglesias A
Bioessays; 2023 Oct; 45(10):e2300038. PubMed ID: 37170707
[TBL] [Abstract][Full Text] [Related]
17. High-Resolution Regulatory Maps Connect Vascular Risk Variants to Disease-Related Pathways.
Åkerborg Ö; Spalinskas R; Pradhananga S; Anil A; Höjer P; Poujade FA; Folkersen L; Eriksson PP; Sahlén P
Circ Genom Precis Med; 2019 Mar; 12(3):e002353. PubMed ID: 30786239
[TBL] [Abstract][Full Text] [Related]
18. Systems Genetics in Human Endothelial Cells Identifies Non-coding Variants Modifying Enhancers, Expression, and Complex Disease Traits.
Stolze LK; Conklin AC; Whalen MB; López Rodríguez M; Õunap K; Selvarajan I; Toropainen A; Örd T; Li J; Eshghi A; Solomon AE; Fang Y; Kaikkonen MU; Romanoski CE
Am J Hum Genet; 2020 Jun; 106(6):748-763. PubMed ID: 32442411
[TBL] [Abstract][Full Text] [Related]
19. Tissue-specific enhancer-gene maps from multimodal single-cell data identify causal disease alleles.
Sakaue S; Weinand K; Isaac S; Dey KK; Jagadeesh K; Kanai M; Watts GFM; Zhu Z; ; Brenner MB; McDavid A; Donlin LT; Wei K; Price AL; Raychaudhuri S
Nat Genet; 2024 Apr; 56(4):615-626. PubMed ID: 38594305
[TBL] [Abstract][Full Text] [Related]
20. A comprehensive integrated post-GWAS analysis of Type 1 diabetes reveals enhancer-based immune dysregulation.
Kim SS; Hudgins AD; Yang J; Zhu Y; Tu Z; Rosenfeld MG; DiLorenzo TP; Suh Y
PLoS One; 2021; 16(9):e0257265. PubMed ID: 34529725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
